Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Amarin Corporation (AMRN) has a market cap of $0.20 billion USD. According to our data, Amarin Corporation is ranked No.6959 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.20 B |
0.80%
|
| Dec 31, 2024 | $0.20 B |
-43.68%
|
| Dec 29, 2023 | $0.36 B |
-28.10%
|
| Dec 30, 2022 | $0.50 B |
-64.09%
|
| Dec 31, 2021 | $1.39 B |
-31.08%
|
| Dec 31, 2020 | $2.01 B |
-77.19%
|
| Dec 31, 2019 | $8.82 B |
57.53%
|
| Dec 31, 2018 | $5.60 B |
239.40%
|
| Dec 29, 2017 | $1.65 B |
30.19%
|
| Dec 30, 2016 | $1.27 B |
62.96%
|
| Dec 31, 2015 | $0.78 B |
92.86%
|
| Dec 31, 2014 | $0.40 B |
-50.25%
|
| Dec 31, 2013 | $0.81 B |
-75.65%
|
| Dec 31, 2012 | $3.33 B |
8.01%
|
| Dec 30, 2011 | $3.08 B |
-8.66%
|
| Dec 31, 2010 | $3.37 B |
473.43%
|
| Dec 31, 2009 | $0.59 B |
101.41%
|
| Dec 31, 2008 | $0.29 B |
-72.69%
|
| Dec 31, 2007 | $1.07 B |
-88.60%
|
| Dec 29, 2006 | $9.38 B |
90.00%
|
| Dec 30, 2005 | $4.94 B |
-55.72%
|
| Dec 31, 2004 | $11.15 B |
75.97%
|
| Dec 31, 2003 | $6.33 B |
-61.40%
|
| Dec 31, 2002 | $16.41 B |
-77.03%
|
| Dec 31, 2001 | $71.45 B |
215.82%
|
| Dec 29, 2000 | $22.62 B |
15.79%
|
| Dec 31, 1999 | $19.54 B |
33.33%
|
| Dec 31, 1998 | $14.65 B |
-88.60%
|
| Dec 31, 1997 | $128.54 B |
-46.24%
|
| Dec 31, 1996 | $239.09 B |
-35.42%
|
| Dec 29, 1995 | $370.20 B |
38.46%
|
| Dec 30, 1994 | $267.37 B |
-25.71%
|
| Dec 31, 1993 | $359.92 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
Denmark
|
| Market Cap | = | AMRN Stock Price | * | AMRN Shares Outstanding |
| = | $9.81 | * | 20.71 M | |
| = | $0.20 B |